Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
ONCY
ONCY
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ONCY News
Oncolytics Biotech Receives FDA Fast Track Designation
Feb 05 2026
PRnewswire
Precision Biologics Market Awakens to $71 Billion Opportunity
Feb 05 2026
Globenewswire
FDA Accelerates Oncology Drug Approvals, Boosting Market Potential
Feb 05 2026
Newsfilter
Precision Biologics Market Awakens to $71 Billion Opportunity
Feb 05 2026
Newsfilter
Oncolytics Biotech Receives FDA Fast Track Designation for Pelareorep
Feb 04 2026
seekingalpha
Oncolytics Receives FDA Fast Track Designation for Pelareorep
Feb 04 2026
Newsfilter
Oncolytics Biotech Strengthens Leadership Amid FDA Approval Surge
Jan 30 2026
PRnewswire
Oncolytics Biotech's Breakthroughs in Cancer Treatment
Jan 30 2026
PRnewswire
Oncolytics Biotech Strengthens Leadership Amid FDA Approval Surge
Jan 30 2026
Newsfilter
Oncolytics Biotech's Breakthroughs in Cancer Treatment
Jan 30 2026
Newsfilter
Oncolytics Biotech Strengthens Leadership Amid Oncology Market Surge
Jan 28 2026
PRnewswire
Oncolytics Biotech Strengthens Leadership to Advance Clinical Programs
Jan 28 2026
Newsfilter
Oncolytics Biotech Strengthens Leadership Amid Oncology Market Surge
Jan 27 2026
Newsfilter
Oncolytics Biotech Strengthens Leadership for Oncology Trials
Jan 27 2026
PRnewswire
Global Market Enters Defensive Cycle of Resilience
Jan 26 2026
Globenewswire
Oncolytics Biotech Accelerates Cancer Treatment with New Executive Appointments
Jan 14 2026
Newsfilter
Show More News
